FDA Approved: INGREZZA SPRINKLE — Supplemental Application (Neurocrine Biosciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application to add INGREZZA SPRINKLE (valbenazine) as a sprinkle formulation for tardive dyskinesia, including use for patients who …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tardive Dyskinesia

Drugs mentioned

• INGREZZA SPRINKLE (valbenazine)

Snippet

SUPPL AP for INGREZZA SPRINKLE (VALBENAZINE)